SecBot SecBot
8-K ·Filed Jul 15, 2026

PROF

Profound Medical Corp.
NEUTRAL
Impact 2/10
Horizondays Processed4mo ago SEC0001171843-26-004654
8-K context-dependent: Items 7.01
Actionable Insight • Neutral

This is a routine conference announcement with no material financial data. The investor session with sell-side analysts could generate modest attention, but no concrete catalysts are provided. Monitor for any data readouts from the CAPTAIN trial or other presentations that could move the stock.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$6.96
T+0 close · Jul 15, 2026 · via day close
Latest settled
−0.72%
T+60 · $6.91
Vs SPY
−3.25%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 15 $6.96entry
  2. T+1 · 4mo ago −2.59%α −2.04% · $6.78
  3. T+5 · 4mo ago +0.43%α +1.41% · $6.99
  4. T+20 · 3mo ago −0.43%α −2.77% · $6.93
  5. T+60 · 6w ago −0.72%α −3.25% · $6.91
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Profound Medical announced its TULSA Procedure will be featured in multiple presentations at the Society of Robotic Surgery Annual Meeting (SRS2026) in Fort Lauderdale, July 23-26, 2026. The company was also selected as one of eight companies for the Society of Incisionless Surgery plenary session, and management will participate in an investor session moderated by Stifel and Wells Fargo analysts. No financial data or guidance was provided.

Key Facts

  • TULSA Procedure highlighted in several presentations at SRS2026 (July 23-26, 2026)
  • CAPTAIN randomized controlled trial primary safety outcomes to be presented
  • Profound selected as one of only eight companies for SIS plenary session
  • Management to participate in investor session moderated by Stifel and Wells Fargo analysts on July 22, 2026

Financial Impact

No financial figures disclosed; routine conference presence announcement

Risk Factors

  • No new financial or operational guidance provided
  • Conference presentations may not lead to material commercial impact

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
80% bullish (5 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001171843-26-004654
Exhibit: exh_991.htm0001171843-26-004654
Document: 0001171843-26-004654-index-headers.html0001171843-26-004654
Document: 0001171843-26-004654-index.html0001171843-26-004654
Document: 0001171843-26-004654.txt0001171843-26-004654

US Market Status

Market Closed · Opens Wed (9h 59m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 15, 2026